For the first quarter of 2008, Quest Diagnostics pulled in $1.8 billion, which is up almost 17 percent over the first quarter of 2007. Clinical testing revenue—which account for 90 percent of the company’s total revenues—was up 17 percent compared to the previous year, with AmeriPath contributing 14 percent to this increase. Net income totaled almost $140 million, up 32 percent from $105.9 million a year ago.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

May 2008 - Table of Contents

LIR May 2008 (full PDF issue)

Injunction in Hand, Industry Focuses on Repealing Competitive Bidding Demo

Medicare Part B Lab Spending Inches Up 1.6% to $6.8B

Future of Carilion Labs in Question

AmeriPath Helps Boost Quest’s Q1 Revenues Up 16.9% to $1.8B Over Prior Year

Global Lab M&A Market Totaled $38M in Q1 2008

Lab Industry Celebrates Temporary Injunction as Fight Continues to Repeal Competitive Bidding Demo

Denver’s National Jewish Medical Opens $1 Million+ Molecular Dx Lab

Pathologists Fight United Healthcare for Nonpayment in Class Action Suit

Third Wave Teams With DCL Medical Labs for Molecular Dx Partnership

Lab Stocks Post Slight Rebound in April; Index Up 1% Over 5 Weeks

Hawaii Enlists Regional Labs to Expand Flu Testing